Fundraising FoxAIQ
New York, US · Founded 2010 · 10 known investors
Find your way into AIQ
Sign up to see every warm intro you have to AIQ
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AIQ team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AIQ Solutions develops intellectual property and technologies to improve clinical treatment outcomes for patients with complex diseases globally. The company combines scientific innovation with clinical validation to support clinician decision-making.
Founders & leadership
Board
Investors · 10
How we know: Alumni Ventures's portfolio page · Not right? Tell us
How we know: Aurora Forge's portfolio page · Not right? Tell us
How we know: Bascom Ventures's portfolio page · Not right? Tell us
How we know: Basecamp Fund's portfolio page · Not right? Tell us
How we know: Capital Midwest Fund's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: New York Angels's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Rock River Capital Partners's portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2014
▶$1.5MraisedApr 2014 · 13 investors · Other TechnologyRule 506(b)
- William O'ConorDirector
- T. Gary LibermanExecutive Officer
- Nicholas W. StullerExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.5M
- First sale
- Mar 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $881.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $388.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does AIQ do?
- AIQ Solutions develops intellectual property and technologies to improve clinical treatment outcomes for patients with complex diseases globally. The company combines scientific innovation with clinical validation to support clinician decision-making.
- Who are AIQ's investors?
- AIQ's investors include Alumni Ventures, Aurora Forge, Bascom Ventures, Basecamp Fund, Capital Midwest Fund, New York Angels, Rock River Capital Partners, Tundra Angels and 2 more.
- How much funding has AIQ raised?
- AIQ has disclosed $1.5M raised across 1 round.
- Where is AIQ headquartered?
- AIQ is headquartered in New York, US.